• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Philips names Roy Jakobs as CEO amid ventilator, CPAP recalls

Philips names Roy Jakobs as CEO amid ventilator, CPAP recalls

August 16, 2022 By Danielle Kirsh

roy jakobs-philips ceo
The plan is for Roy Jakobs to become Philips’s president and CEO, effective October 15. [Image courtesy of Royal Philips]
Philips (NYSE:PHG) today announced that it plans for Roy Jakobs to succeed Frans van Houten as president and CEO, effective October 15.

The Amsterdam-based company’s supervisory board and CEO van Houten have agreed that it is time for a change in leadership as his third term in the corner office ends. The board unanimously decided to propose Jakobs succeed van Houten.

The move comes as the Dutch medtech giant grapples with a serious respiratory devices recall. The recall involves more than 1 million ventilator and CPAP devices and is linked to 124 deaths. Van Houten disclosed during Philips’s most recent earnings call that the U.S. Department of Justice has proposed a consent decree on behalf of the FDA.

Feike Sijbesma, the chairperson of Royal Philips’ supervisory board, thanked van Houten for “his transformational leadership of Philips over the last nearly 12 years.”

“Guided by his vision and the execution of the strategic roadmap, he has successfully led the company’s transformation from a diversified industrial conglomerate into a focused, global solutions leader in health technology,” Sijbesma said in a news release. “Building on its 131-year heritage, he repositioned Philips to significantly enhance the future value-creating prospects of the company. Frans led Philips with genuine care for its customers, patients, and its employees.”

As Philips’s chief business leader of connected care, Jakobs has been responsible for handling the voluntary recall notification and field safety notices for specific Respironics devices on behalf of Philips. He has made progress in the execution of a comprehensive program that delivers a resolution to affected patients as quickly as possible in consultation with relevant competent authorities.

An Extraordinary General Meeting of shareholders will be held on September 30 to officially appoint Jakobs as president and CEO, to be effective October 15. Van Houten will remain as an advisor to the company and support the CEO transition until April 30, 2023.

Jakobs joined Philips in 2010

Jakobs has held various leadership roles at Philips over the years, including chief marketing and strategy officer for Philips Lighting and market leader for Philips Middle East and Turkey across health systems, consumer and lighting. He become chief business leader of personal health in 2018 and was at the forefront of managing the company’s COVID crisis response in early 2020. Jakobs took responsibility in June 2021 to address the Respironics recall on behalf of the company.

“I am delighted to have the opportunity to lead Philips to improve people’s health and well-being through innovation,” Jakobs said in a news release. “I aim to build on the company’s strong foundation as a purpose-driven health technology leader with deep innovation and clinical expertise, to serve the needs of patients and consumers today and in the future. I look forward to working with Philips’ teams across the world to deliver a strong value creation trajectory for shareholders and all our other stakeholders. I also want to take this opportunity to thank Frans for his trust and the great support he has given me over the years.”

Shares in PHG were up 1.39% to $20.38 apiece at market open. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up slightly.

Filed Under: Business/Financial News, Featured, News Well, Respiratory Tagged With: Personnel Moves, Philips, Royal Philips

More recent news

  • Real-world data backs Route 92 reperfusion system
  • LivsMed unveils new surgical robot with telesurgery capabilities
  • JenaValve enrolls first patient in TAVR for AR study
  • HistoSonics expands insurance coverage for histotripsy treatment
  • Johnson & Johnson MedTech gets updated FDA nod for Varipulse PFA

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy